In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1125-80-0, name is 3-Methylisoquinoline, introducing its new discovery. Recommanded Product: 3-Methylisoquinoline
Asymmetric synthesis of a TRPV1 antagonist via tert -butanesulfinamide- directed reductive amination with a chromanone
An expedient asymmetric synthesis of TRPV1 antagonist 1 has been developed and demonstrated on multikilogram scale. The enabling route to 1 is detailed herein and characterized by the following key transformations: an aldol-cyclodehydration sequence to install the chromanone, and an auxiliary-mediated diastereoselective reductive amination.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1125-80-0, and how the biochemistry of the body works.Recommanded Product: 3-Methylisoquinoline
Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H41N – PubChem